Emma Carson1, Rachel Dear2. 1. MB, BCh, BAO, Medical Oncology advanced trainee, Kinghorn Cancer Centre, St Vincent’s Hospital, Darlinghurst, NSW; Conjoint Associate Lecturer, Sydney Medical School, University of New South Wales, NSW. emmakate.carson@health.nsw.gov.au 2. MBBS, FRACP, PhD, Medical Oncologist, Kinghorn Cancer Centre, St Vincent’s Hospital, Darlinghurst, NSW; Sydney Medical School, University of Sydney, Chris O’Brien Lifehouse, Camperdown, NSW
Abstract
BACKGROUND: Breast cancer is the most common cancer in women in Australia. Breast cancer is a heterogeneous disease; subtypes are defined by their biology with prognostic and therapeutic implications. Advancements in treatment have led to improved survival and quality of life for patients with advanced breast cancer. OBJECTIVE: The aim of this article is to provide a concise update regarding the current systemic management of advanced breast cancer, including novel treatment options. DISCUSSION: The aim of treatment in advanced breast cancer is to prolong life, manage symptoms and improve quality of life. The general practitioner is an important member of the patient’s multidisciplinary team.
BACKGROUND:Breast cancer is the most common cancer in women in Australia. Breast cancer is a heterogeneous disease; subtypes are defined by their biology with prognostic and therapeutic implications. Advancements in treatment have led to improved survival and quality of life for patients with advanced breast cancer. OBJECTIVE: The aim of this article is to provide a concise update regarding the current systemic management of advanced breast cancer, including novel treatment options. DISCUSSION: The aim of treatment in advanced breast cancer is to prolong life, manage symptoms and improve quality of life. The general practitioner is an important member of the patient’s multidisciplinary team.